VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants

Abstract excerpt

Virus-like particles (VLPs) are a versatile, safe, and highly immunogenic vaccine platform. Recently, there are developmental vaccines targeting SARS-CoV-2, the causative agent of COVID-19. The COVID-19 pandemic affected humanity worldwide, bringing out incomputable human and financial losses. The race for better, more efficacious vaccines is happening almost simultaneously as the virus increasingly produces...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bacterial Infections and Vaccines
• Share to SARS-CoV-2 and COVID-19 Research
• Share to vaccines and immunoinformatics approaches